Rising incidence of healthcare associated infections is driving the growth of the Sterilization Technology Market
Sterilization technology market was valued at $4.1 billion in 2016 and is projected to cross $7.0 billion by 2023, growing …
Read More 
The switch from analog to digital technologies is driving the machine translation market
Machine translation market was valued at $122.3 million in 2016 and is projected to cross $195.0 million by 2023, growing …
Read More
Patient care and sickness related to radiation is driving the growth of the Radiation Dose Management Market
Radiation dose management (RDM) market was valued at $129.8 million in 2016 and is projected to cross $1,600.0 million by …
Read More
Volkswager CEO tells Welt am Sonntag that VW may post excellent 2017 results
Volkswagen will report excellent group results this year, its chief executive said, helped by expected record vehicle sales and by spending …
Read More
DFS buys assets from failed Multiyork
DFS Furniture has bought store leases and other assets from failed rival, Multiyork. Multiyork, based in Thetford Norfolk, had 50 …
Read More
Wireless charging company Energous jumps 271% this week
This is what you call a year-end rally. Shares of wireless charging company Energous have more than tripled this week after the …
Read More
Apple apologizes for slowing down the older iPhones
Apple has apologised after facing criticism for admitting it deliberately slows down some ageing iPhone models. The company now says …
Read More
Softbank takes large stake in Uber
Japanese giant Softbank is set to take a large stake in Uber, expanding its holdings in transportation companies around the …
Read More
US cancer drugmaker Ignyta to be bought by Roche for $1.7 billion
Swiss drugmaker Roche will buy U.S. cancer drugmaker Ignyta Inc for $1.7 billion to broaden its oncology portfolio globally, the companies said on Friday. …
Read More
Sucampo to be bought by Mallinckrodt for about $840 million
Drugmaker Mallinckrodt said on Tuesday it would buy Sucampo Pharmaceuticals for about $840 million, excluding debt, to gain access to its constipation drug, Amitiza. …
Read More